Isoniazid (INH) has been a first-line drug for tuberculosis treatment for many years and yet its mechanism of action remains only partially understood (Rozwarski et al. 1998 , Heym et al. 1999 ). Molecular studies have demonstrated that mutations in katG and inhA (regulatory and structural regions) confer resistance to INH in Mycobacterium tuberculosis (Telenti 1998) . Mutations in oxyR-ahpC intergenic region are considered a compensatory mechanism for the loss of KatG enzyme activity in resistant strains (Sherman et al. 1996 , Ramaswamy & Musser 1998 
Isoniazid (INH) has been a first-line drug for tuberculosis treatment for many years and yet its mechanism of action remains only partially understood (Rozwarski et al. 1998 , Heym et al. 1999 ). Molecular studies have demonstrated that mutations in katG and inhA (regulatory and structural regions) confer resistance to INH in Mycobacterium tuberculosis (Telenti 1998) . Mutations in oxyR-ahpC intergenic region are considered a compensatory mechanism for the loss of KatG enzyme activity in resistant strains (Sherman et al. 1996 , Ramaswamy & Musser 1998 and can be used as a surrogate marker for detection of resistance to INH in M. tuberculosis (Wilson et al. 1998 ). Other putative mechanisms that can result in resistance to INH are less well understood (Zang & Telenti 2000 , Larsen et al. 2002 .
Prior studies (Chen & Bishai 1998 , Miesel et al. 1998 (Kent & Kubica 1985) and genotyped using the spoligotyping method (Molluizen et al. 1998 ). Susceptibility to INH was determined using the proportion method in Löwenstein-Jensen medium (BD/Becton, Dickinson and Co. Sparks, MD, US) according to Canetti et al. (1963) . The minimal inhibitory concentration (MIC) of INH was determined for all isolates using the Microplate Alamar Blue Assay (MABA) (Franzblau et al. 1998) . The isolates were cultured in Middlebrook 7H9 broth with oleic acid-albumin-dextrose-catalase (OADC) Enrichment (BBL/ Becton, Dickinson) containing two-fold serial dilution of INH, ranging from 32.0 to 0.25 µg/ml. The visual MIC value was defined as the lowest INH concentration that prevented a color change of the Alamar Blue reagent (Accumed International, Westlake, OH, US) from blue to pink. A blue color in the well was interpreted as absent (inhibit grow-up of 90%) of mycobacterial growing. According to Franzblau et al. (1998) , in this study, the M. tuberculosis isolates were considered susceptible to INH when showed MIC value ≤ 0.25 µg/ml.
In all isolates studied here, an earlier report describes the genotypic analysis by polymerase chain reactionsingle-strand conformation polymorphism analysis (PCR-SSCP) targeting the codons 16 (region -7 to 67) and 94 (region 65 to 125) of inhA, the oxyR-ahpC intergenic region and the entire kasA gene by amplifying six overlapping fragments. Sequencing was performed of the genes fragments that presented PCR-SSCP patterns different from wild type ones and of the entire katG gene of all strains studied in this work (Cardoso et al. 2004 ).
The chromosomal DNA was extracted as described earlier (Gonzalez-y-Merchand et al. 1996) with modifications introduced in our laboratory (Cardoso et al. 2004 ). The entire ndh gene was PCR amplified in five overlapping fragments according to Lee et al. (2001) . The PCR products were generated using the Hotstart Taq TM Master Kit (Qiagen Inc. Valencia, CA, US) according to the manufacturer's instructions with 1 µl of template genomic DNA in a final reaction volume of 25 µl in a Gene Amp System 2400 thermalcycler (PE Applied Biosystems Corp., Foster City, CA, US). Sequencing reactions were performed using the ABI Prism BigDye terminator Cycle Sequencing Kit (PE Applied Biosystems Corp.) according to the manufacturer's instructions in a Gene Amp PCR System 9700 ther-malcyrcler (PE Applied Biosystems Corp.). Sequencing products were purified using CENTRI-SEP Colums (Princeton Separations, Inc. Adelphia, NJ, US) and electrophoresed on an ABI Prism 373XL automatic sequencer (PE Applied Biosystems Corp.). Sequence data were assembled and edited electronically using ABI PRISM DNA Sequencing Analysis Software version 3.0 (PE Applied Biosystem Corp.) and the results compared to the sequence for ndh of M. tuberculosis H37Rv present in GeneBank (acession no. Z838559).
From the 23 INH-resistant M. tuberculosis clinical isolates studied, ndh gene mutations were detected in two (8.7%) and no mutation was detected in the 13 INHsusceptible isolates (Table) . One isolate (INH MIC > 32.0 µg/ml) presented mutation in codon 13 (CGT to TGT), resulting in an R 13 C amino acid change and in other (INH MIC 32.0 mg/ml) the mutation was in codon 18 (GTG to GCG) resulting in a V 18 A amino acid change. The R 13 C mutations detected in our work occurred at different locations from those previously reported ndh either in M. smegmatis (Chen & Bishai 1998 , Miesel et al. 1998 or in clinical isolates of M. tuberculosis (Lee et al. 2001 , Ramaswamy et al. 2003 but the V 18 A mutation was reported by Ramaswamy et al. (2003) in susceptible M. tuberculosis isolates.
It was verified that both INH-resistant isolates, that presented mutation in ndh, also had a mutation in katG (one of them with point mutation in codon no. 315, resulting in a S 315 T and in the other isolate, insertion of A at nucleotide position 17 of katG) detected in our previous study (Cardoso et al. 2004 ). According to Ramaswamy and Musser (1998), Zhang and Telenti (2000) , van Soolingen et al. (2002) , isolates with katG mutation, show MIC value consistent with of the INH-resistant isolates, suggesting that resistance was due to mutation in katG. In this sense, the contribution of ndh mutation to the INH resistance phenotype is unknown. Considering the recent demonstration that mutations in the ndh gene of M. bovis BCG mediate INH and ETH resistance (Vilchèze et al. 2005) it seems probable that such mutation could have a similar effect in M. tuberculosis. The R 13 C ndh mutants identified in this study might prove useful in demonstrating the involvement of this mechanism in M. tuberculosis. Further investigation is needed to establish the role and prevalence of ndh mu- Two INH-resistant isolates studied here (INH MIC 2.0 and > 32.0 µg/ml) that showed no mutation in ndh genes also were negative to katG, inhA, kasA, or in the oxyR-ahpC intergenic region mutation in the previous study (Cardoso et al. 2004 ). This suggests the existence of additional INH resistance mechanism. These isolates are therefore good candidates for further investigation of alternative mechanisms.
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